Advanced Biomed Inc Research and Development Expense
Advanced Biomed Inc (ADVB) reported Research and Development Expense of $243.23 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-15
- Advanced Biomed Inc research and development expense for the quarter ending 2026-03-31 was $243.23K, a 10.57% increase year-over-year.
- Advanced Biomed Inc research and development expense for the quarter ending 2025-12-31 was $186.33K, a 12.27% decline year-over-year.
- Advanced Biomed Inc research and development expense for the quarter ending 2025-09-30 was $235.99K, a 29.88% increase year-over-year.
- Advanced Biomed Inc research and development expense for the quarter ending 2025-06-30 was $309.71K, a 48.11% increase year-over-year.
- Advanced Biomed Inc research and development expense for fiscal 2025 was $909.77K, a 3.36% increase from fiscal 2024.
- Advanced Biomed Inc research and development expense for fiscal 2024 was $880.19K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $243.23K 10-Q · filed 2026-05-15 | $429.56K derived: sum of 2 quarters · filed 2026-05-15 | $665.14K 10-Q · filed 2026-05-15 | $975.26K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $186.33K 10-Q · filed 2026-02-13 | $421.91K 10-Q · filed 2026-02-13 | $732.04K derived: sum of 3 quarters · filed 2026-02-13 | $952.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-09-30 | $235.99K 10-Q · filed 2025-11-19 | $545.71K derived: sum of 2 quarters · filed 2025-11-19 | $765.67K derived: sum of 3 quarters · filed 2026-05-15 | $978.07K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $309.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $529.68K derived: sum of 2 quarters · filed 2026-05-15 | $742.08K derived: sum of 3 quarters · filed 2026-05-15 | $909.77K 10-K · filed 2025-10-08 | |||
| 2025-03-31 | $219.97K 10-Q · filed 2026-05-15 | $250.46K 10-Q · filed 2025-05-15 | $432.36K derived: sum of 2 quarters · filed 2026-05-15 | $600.06K 10-Q · filed 2026-05-15 | $675.55K 10-Q · filed 2025-05-15 | $823.18K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $212.40K 10-Q · filed 2026-02-13 | $243.38K 10-Q · filed 2025-04-15 | $380.09K 10-Q · filed 2026-02-13 | $425.08K 10-Q · filed 2025-04-15 | $603.21K derived: sum of 3 quarters · filed 2026-02-13 | $916.72K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $181.70K 10-Q · filed 2025-11-19 | $390.81K derived: sum of 2 quarters · filed 2025-11-19 | $704.32K derived: sum of 3 quarters · filed 2025-11-19 | $892.71K derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $209.11K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $522.62K derived: sum of 2 quarters · filed 2025-10-08 | $711.01K derived: sum of 3 quarters · filed 2025-10-08 | $880.19K 10-K · filed 2025-10-08 | |||
| 2024-03-31 | $313.51K 10-Q · filed 2025-05-15 | $501.90K derived: sum of 2 quarters · filed 2025-05-15 | $671.08K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $188.39K 10-Q · filed 2025-04-15 | $357.57K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |